CDISC Data Standard Could Overhaul Data Submission Process

Drug Industry Daily
A A
The Clinical Data Interchange Standard Consortium (CDISC) is asking for input on a new data submission standard that could give clinical trial sponsors and reviewers greater flexibility if adopted by the FDA for drug review applications.

To View This Article:

Login

Subscribe To Drug Industry Daily